SELP and breast carcinoma: In breast cancer, the loss of P-selectin inhibited the infiltration of regulatory T-cells and reduced levels of proinflammatory cytokines, such as IL-4, IL-10, and TGF-β, were measured in the tumors resulting in a better survival ratio [106].